Draft:Tarek Fahmy
Biomedical engineer and academic
From Wikipedia, the free encyclopedia
Tarek Fahmy is a biomedical engineer and academic at Yale University. He is an associate professor of biomedical engineering and immunobiology whose research focuses on biomaterials, drug delivery, and immunoengineering.[1][2] He is known for work on biodegradable artificial antigen-presenting cells and nanogel-based delivery systems for cancer immunotherapy and autoimmune disease treatment.[3][4][5]
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
Comment: Notability is currently unclear. While he has significant citations, many are team papers where his role is unclear. Ldm1954 (talk) 12:55, 19 May 2026 (UTC)
Education and career
Fahmy received a B.Sc. from the University of Delaware, followed by an M.S. and Ph.D. from Johns Hopkins University.[6] He later joined the Yale faculty and holds appointments in biomedical engineering and immunobiology.[1][2]
Research
Fahmy's research focuses on the design of biomaterials for drug and antigen delivery to the immune system.[1][7] His laboratory has developed nanoscale biomaterial systems for immune modulation including artificial antigen presenting cells and nanogel drug-delivery platforms.
In 2008, Fahmy and Erin R. Steenblock reported a biodegradable polymeric artificial antigen-presenting cell platform for ex vivo T-cell expansion.[3] The work was described by the U.S. National Science Foundation as a method for training T cells to recognize cancer cells outside the body before returning them to a patient.[7]
Subsequent work from his laboratory examined the use of carbon nanotube bundles to enhance T-cell activation for adoptive immunotherapy.[8]
In 2012, Fahmy and collaborators reported a nanolipogel platform that co-delivered interleukin-2 and a TGF-β receptor inhibitor to tumors.[9] A Nature Materials News & Views article described the approach as engaging both innate and adaptive immune responses in tumour immunotherapy.[4] Independent coverage by ecancer described the sustained-delivery system as designed by "Tarek Fahmy and his co-workers" at Yale.[10]
Fahmy's group also applied nanogel delivery methods to autoimmune disease.[5] His work was highlighted by the Journal of Clinical Investigation and by Yale News as a potential targeted therapy for autoimmune disease.[11][12][13]
In 2016, Yale announced that a nanogel-based immunotherapy platform developed in Fahmy's laboratory was moving toward a first phase of clinical trials for metastatic cancer.[14]
Honors
Fahmy received a Wallace H. Coulter Foundation Early Career Award in 2006.[1] He later received an NSF CAREER Award for research on biomaterials designed to manipulate immune responses against cancer and other diseases.[7]
Selected publications
- A comprehensive platform for ex vivo T-cell expansion based on biodegradable polymeric artificial antigen-presenting cells (2008)[3]
- Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy (2012)[9]
- Nanogel-based delivery of mycophenolic acid ameliorates systemic lupus erythematosus in mice (2013)[5]
or multiple published secondary sources that:
- provide significant coverage: discuss the subject in detail, not just brief mentions or routine announcements;
- are reliable: from reputable outlets with editorial oversight;
- are independent: not connected to the subject, such as interviews, press releases, the subject's own website, or sponsored content.
Please add references that meet these criteria. If none exist, the subject is not yet suitable for Wikipedia.